From #AACR24 presentation to AACR recap, this team is always hard at work, having fun, and dedicated to advancing pancreatic cancer treatments. Big thanks to Jordan M. Winter MD for bringing this group together and leading them like the stars they are! 🌟 Case Comp Cancer Ctr University Hospitals

#Neoadjuvant therapy for #melanoma is the new kid on the block. Our analysis provides guidance on the choice of regimen. Read on! jamanetwork.com/journals/jamao…
Doctors Weigh Patient Goals Instead of ‘Dictating’ Melanoma Treatment curetoday.com/view/doctors-w… via CURE Today

Luke Rothermel, MD, MPH joins us as the next #ResearcherSpotlight ! Luke D. Rothermel is an Assistant Professor of Surgery here at UH Surgical Oncology. Follow along to learn more about his research in CLE!

Just released! Great to moderate this Society of Surgical Oncology podcast on #Merkelcellcarcinoma #skincancer with James Jakub Luke D. Rothermel surgonctoday.libsyn.com/only-merkel-ce… Fox Chase Cancer Center @
NCCN ACS Cancer Programs American College of Surgeons American Cancer Society The ASCO Post AADmember @derm was my

⚡️Hot off the press⚡️. Our analysis of data from neoadjuvant IO trials in melanoma published in JAMA Oncology. The phenomenal John M. Kirkwood mentored our team to develop this paper 🙏🏼. Ipi3-nivo1 or ipi1-nivo3 or anti-pd1- which one to give? We provide some answers in this paper. National Comprehensive Cancer Network (NCCN)

Great final conference and exclamation point for a prolific research fellowship

Thank you Hanna Kakish حنا قاقيش for your hard work and dedication

Coming your way this summer Fabian Johnston, M.D., M.H.S Katie Bingmer

Fun today recording Society of Surgical Oncology Podcast on #MerkelcellCarcinoma #SSO2024 AnnalsSurgOncology National Comprehensive Cancer Network (NCCN) Fox Chase Cancer Center Fox Chase Surgical Oncology

Coming soon to wherever u listen to your podcast. Merkel cell carcinoma live from #SSO2024
Always a privilege to interact with colleagues and learn from these 2 experts
Jeffrey Farma Luke D. Rothermel

#Melanoma Great debate starting now #Neoadjuvant Therapy Society of Surgical Oncology #SSO2024 packed room Charlotte Ariyan Alex Van Akkooi Melanoma Research Foundation Melanoma Research Melanoma Institute Australia AnnalsSurgOncology AIM at Melanoma Foundation

Non-melanoma skin cancers are often overshadowed, yet they present a major burden to the healthcare system. Consider submitting your next paper to this special collection, which includes cutaneous lymphoma and cutaneous sarcoma research. AAD AmericanSkinAssociation The Skin Cancer Foundation 👒

Team UH Surgery Residents UH Surgical Oncology at #SSO2024 ! 💙 Victoria Wu Richard Hoehn Hanna Kakish حنا قاقيش Luke D. Rothermel

Great study by Hanna Kakish حنا قاقيش exploring disparities in cancer surgery

I am extremely thankful and humbled to be joining the surgery team at Hopkins Surgery
Thank you for placing your trust in me. I am humbled by the opportunity to be part of this family

Excellent perspective and a good reminder that despite EMR mandates, medicine is a profession of humanity, not one that is best accomplished looking at a computer screen. A corollary: administrative quantitative fallacy is the most important contributor of physician burnout.

An updated review of the management of patients with desmoid tumors - Ankit Mangla, MD
Case Comp Cancer Ctr
oncodaily.com/35247.html

#Cancer #OncoDaily #Oncology #OvarianDysfunction #Cancer Care

Today, the U.S. FDA approved a groundbreaking treatment called #TILTherapy for advanced #melanoma . We are grateful Moffitt Cancer Center could play an integral role in the development of this lifesaving therapy.

Read more NBC News: nbcnews.to/3UGqLfS

Excellent work Ankit Mangla, MD Case Comp Cancer Ctr! A very helpful review of the management of Desmoid Tumors. Such a challenging disease for patients and physicians.

Delayed melanoma surgery may impact cancer-specific survival

Great work Susie! UH Surgical Oncology UH RISES UH Research & Education Institute Luke D. Rothermel Hanna Kakish حنا قاقيش

225pts +SLN for #melanoma and no CLND, 80 recurred.
24 (30%) 1st recurrence in same basin as the +SLN, only 1/2 of these confined to the LNs.

In pts w/ surveillance US and PET scan, PET picked up all nodal recurrences seen by US. Can we drop regional nodal US if obtaining PET?

Our recent commentary of the HIPECT4 trial and current evidence for patients with advanced colon cancer

⁦UH Surgical Oncology⁩ ⁦UH Research & Education Institute⁩ ⁦John Ammori⁩ ⁦Luke D. Rothermel ⁦Jordan M. Winter MD⁩ Ronald A Charles, MD⁩ @doctorc369 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…